Letters, Statements & Analysis

AMCP communicates the importance of managed care pharmacy by collaborating with members to provide comments, analysis, and testimony to Congress and federal and state agencies on the impact of proposed regulations and laws on managed care pharmacy and patients.

Capitol Hill, U.S. Capitol, IRA Workshop

AMCP Comments on the 2025 Medicare Physician Fee Schedule

On September 9, AMCP submitted comments praising CMS’s proposal to cover Digital Mental Health Treatment devices (DMHTs) under Medicare Part B. AMCP urges CMS to use its authority to cover all FDA-cleared, prescription only digital health products and develop appropriate coding and payment methodologies to promote adoption of these innovative technologies.
Medicare

AMCP, Patient and Provider Groups Applaud Supreme Court Ruling on Alliance for Hippocratic Medicine et al. v FDA et al

On June 13, AMCP joined 24 patient and provider organizations in applauding the Supreme Court's unanimous ruling reversing the Fifth Circuit's decision in Alliance for Hippocratic Medicine et al. v FDA et al. AMCP and the undersigned organizations unequivocally support FDA's role in safeguarding patients, which has yielded approval of tens of thousands of crucial medications and devices for generations of Americans.
Legislation & Regulation

AMCP Expresses Concerns with State Legislation Restricting Managed Care Pharmacists

On May 29, AMCP released the following statement, which expresses concerns about the Illinois General Assembly's Healthcare protection Act (HB 5395). Passed on May 25, the bill restricts managed care pharmacists' ability to manage prescription drug benefits for millions of Illinoisans covered under the state’s Medicaid program, state employee group insurance, and fully insured commercial plans.
Legislation & Regulation

AMCP Comment Letter on MPPP Model Documents

On Feb. 29, 2024, the Centers for Medicare and Medicaid Services (CMS) issued The Medicare Advantage and Prescription Drug Programs: Part C and Part D Medicare Prescription Payment Plan Model Documents. AMCP submitted comments in response to this Model Documents on April 29, 2024.
Legislation & Regulation

AMCP Comments on Medicare Prescription Payment Plan: Draft Part Two Guidance

On Feb. 15, 2024, the Centers for Medicare and Medicaid Services (CMS) issued the Medicare Prescription Payment Plan: Draft Part Two Guidance and a Fact Sheet to provide guidance on education and outreach requirements for the Medicare Prescription Payment Plan (M3P), which was established by the Inflation Reduction Act (IRA). AMCP submitted comments in response to this Guidance on March 15, 2024.
Legislation & Regulation

AMCP Comments on Medicare Prescription Payment Plan: Draft Part Two Guidance

On Feb. 15, 2024, the Centers for Medicare and Medicaid Services (CMS) issued the Medicare Prescription Payment Plan: Draft Part Two Guidance and a Fact Sheet to provide guidance on education and outreach requirements for the Medicare Prescription Payment Plan (M3P), which was established by the Inflation Reduction Act (IRA). AMCP submitted comments in response to this Guidance on March 15, 2024.
Payment Systems

AMCP Comments on Impacts of the Cyberatack on Change Healthcare

In a March 5, 2024 press release, the Department of Health & Human Services (HHS) expressed intent to issue guidance to encourage Medicare Advantage (MA) and Part D plans to relax or remove prior authorization requirements and other utilization management strategies. On March 6, 2024, CMS issued a memo encouraging MA and Part D plans to relax or remove prior authorization requirements in response to the Change Healthcare cyberatack. AMCP sent a letter in response to this guidance on March 8, 2024.
Legislation & Regulation

AMCP Comment on Advance Notice of Methodological Changes for Calendar Year (CY) 2025

On January 31, 2024, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule titled “Advance Notice of Methodological Changes for Calendar Year (CY) 2025”. Each year, CMS is required to update MA payment rates and regularly conducts technical updates through the Advance Notice and Rate Announcement process. AMCP submitted comments in response to this rule on March 1, 2024.
Legislation & Regulation